Publications

AACR 2018 Poster Report of Preclinical Rivoceranib (Apatinib) Combination with Immunotherapy

ACCP 2017 Poster of a Phase 1 Ethnic PK Study

ASCO 2017 Poster Report of Apatinib Phase III Trial in Progress

ESMO 2016 Poster Report of Apatinib Phase II Study Results